CLINICAL OUTCOMES ASSOCIATED WITH SODIUM ZIRCONIUM CYCLOSILICATE FOR TREATING HYPERKALAEMIA IN PATIENTS RECEIVING HAEMODIALYSIS

被引：0
|
作者：
Ferraro, P. M. [1 ]
Booth, D. [2 ]
Silvanto, J. [2 ]
McEwan, P. [2 ]
Rao, N. [3 ]
机构：
[1] Univ Cattolica Sacro Cuore, Dipartimento Univ Med Chirurg Traslazional, Rome, Italy
[2] Hlth Econ & Outcomes Res Ltd, Cardiff, Wales
[3] AstraZeneca, Cambridge, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO35
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [21] ISCHEMIC BOWEL ASSOCIATED WITH SODIUM ZIRCONIUM CYCLOSILICATE
    Yanchuk, Viktoriya
    Weltman, Lames
    Maw, Thin Thin
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 657 - 657
  • [22] Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode
    Pollack Jr, Charles V.
    Arroyo, David
    Kanda, Eiichiro
    Lazaro, Ignacio Jose Sanchez
    Lesen, Eva
    Franzen, Stefan
    Gray, Christen M.
    Lipinska, Anna
    Murohara, Toyoaki
    Rastogi, Anjay
    ESC HEART FAILURE, 2024,
  • [23] SUBGROUP EFFICACY ANALYSIS OF SODIUM ZIRCONIUM CYCLOSILICATE (SZC) IN HYPERKALAEMIC HAEMODIALYSIS PATIENTS IN THE DIALIZE STUDY
    McCafferty, Kieran
    Fishbane, Steven
    Spinowitz, Bruce
    Rastogi, Anjay
    Ford, Martin
    Guzman, Nicolas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 547 - 547
  • [24] Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode
    Arroyo, David
    Pollack Jr, Charles, V
    Kanda, Eiichiro
    Lazaro, Ignacio Jose Sanchez
    Lesen, Eva
    Franzen, Stefan
    Gray, Christen M.
    Murohara, Toyoaki
    Rastogi, Anjay
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [25] CHARACTERISTICS OF PATIENTS RECEIVING SODIUM ZIRCONIUM CYCLOSILICATE DURING HOSPITAL-BASED TREATMENT OF HYPERKALEMIA
    Agiro, A.
    Bhattacharya, A.
    Khan, Z.
    Tung, A.
    Brahmbhatt, Y.
    VALUE IN HEALTH, 2021, 24 : S236 - S236
  • [26] Cost-Effectiveness Analysis of Sodium Zirconium Cyclosilicate for Treating Hyperkalemia Among Chinese Patients
    Tian, L.
    Fu, S.
    Zhao, X.
    Li, M.
    Li, H. C.
    VALUE IN HEALTH, 2022, 25 (12) : S150 - S151
  • [27] Cost-effectiveness analysis of sodium zirconium cyclosilicate for treating hyperkalemia among Chinese patients
    Tian, Lei
    Fu, Shihui
    Li, Mengyuan
    Zhao, Xinrui
    Li, Hongchao
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [28] Managing acute hyperkalaemia in frail individuals using a modern potassium binder sodium zirconium Cyclosilicate (Lokelma®)
    Suman, S.
    Debnath, V
    AGE AND AGEING, 2025, 54 : I5 - I6
  • [29] SODIUM ZIRCONIUM CYCLOSILICATE FOR HYPERKALAEMIA IN PATIENTS WITH DIABETES MELLITUS: RETROSPECTIVE ANALYSIS OF A 12 MONTH OPEN LABEL, PHASE 3 STUDY
    Fishbane, Steven
    Roger, Simon
    Packham, David
    Lavin, Philip
    Adler, Scott
    Lerma, Edgar
    Butler, Javed
    Von Haehling, Stephan
    McCullough, Peter
    Kosiborod, Mikhail
    Spinowitz, Bruce
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [30] Plant-based diet in hyperkalemic chronic kidney disease patients receiving sodium zirconium cyclosilicate: a feasibility clinical trial
    Avesani, Carla Maria
    Heimburger, Olof
    Rubin, Charlotta
    Sallstrom, Torsten
    Faxen-Irving, Gerd
    Lindholm, Bengt
    Stenvinkel, Peter
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2024, 120 (03): : 719 - 726
12345